Sanofi discloses safety signal for dengue vaccine

Sanofi (Euronext:SAN; NYSE:SNY) said it requested that health authorities update the labels for its Dengvaxia tetravalent dengue vaccine (CYD-TDV) after a long-term analysis of

Read the full 245 word article

User Sign In